This trial is fully enrolled. This means that all of the available places on the trial have been filled. You cannot enrol in this trial.
About this trial
This national access study will provide antiretroviral therapy for 48 months to 180 HIV positive people who are legally resident in Australia but ineligible for Medicare access to ARVA medication or other substance which is active against retroviruses such as HIV. drugs.
As well as providing drug access, the study will collate data on this population, including reasons for ineligibility (e.g. visa status and type), the length of time it takes for them to become eligible for Medicare and other information to assist the ongoing advocacy work for those who will not be supported by this program.
As well, the study will collate information on the type of antiretroviral treatment regimens prescribed as well as any changes required; and assess long-term clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. outcomes including immunological and virological response to treatment.
ATRAS is a joint project of NAPWHA and The Kirby Institute and is supported by the seven pharmaceutical companies who provide HIV antiretroviralA medication or other substance which is active against retroviruses such as HIV. drugs in Australia and the Australian HIV Observational Database (AHOD) clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. sites.
|Official title:||AHOD Temporary Residents Access Study|
|What is this trial studying?||Other|
|Start date:||9 November 2011|
This may be the proposed or expected start date for trials which have not yet started.
|How many participants will this trial enrol?||180 |
The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.
|How long is this trial planned to go for?||Participants in this trial will be asked to follow the trial protocol for 48 months.|
Who can enrol in this trial?
You may be eligible to participate in this trial if you meet the following criteria:
- At least 18 years old
- Legally resident in Australia but currently ineligible for Medicare.
This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.